ArticleJournal of thoracic disease2026
A nomogram for in-hospital mortality in the intensive care unit: development and validation with a type B aortic dissection cohort.
Article in Journal of thoracic disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The early recognition of high-risk cases with type B aortic dissection (TBAD) in the intensive care unit (ICU) represents a critical component of effective clinical management. But a specific, practical tool for this purpose is lacking. Our research aimed to fill this need by constructing and validating a specific, validated instrument to predict in-hospital mortality among these individuals. Methods: We obtained patient data consistent with the diagnosis of TBAD from Medical Information Mart for Intensive Care IV (MIMIC-IV) and eICU Collaborative Research Database (eICU-CRD). Missing data in the MIMIC-IV cohort were handled using multiple imputation. In the primary model-development analysis, the Synthetic Minority Over-Sampling Technique (SMOTE) was applied before splitting the data into training and internal validation sets. A nomogram was constructed using the least absolute shrinkage and selection operator (LASSO) and multivariable logistic regression. Model performance was assessed by the area under the receiver operating characteristic curve (AUC), calibration analyses, and decision curve analysis (DCA). Results: For descriptive cohort characteristics, the original non-oversampled cohorts included 341 patients from MIMIC and 76 patients from eICU. For the primary model-development analysis, after multiple imputation and SMOTE, the MIMIC cohort was divided into a training set (n=407) and an internal validation set (n=174), while the eICU cohort served as the external validation set (n=76). Seven predictor variables were determined and used to construct a nomogram. The nomogram demonstrated good discrimination, with AUCs of 0.789 [95% confidence interval (CI): 0.745-0.835] in the training cohort, 0.801 (95% CI: 0.733-0.868) in the internal validation cohort, and 0.792 (95% CI: 0.600-0.955) in the external cohort. In a non-oversampled sensitivity calibration analysis, calibration was good in the original training cohort, acceptable but attenuated in the original internal validation cohort, and less stable in the small complete-case external subset. Conclusions: We constructed and validated a nomogram that can individually predict in-hospital mortality for ICU patients with TBAD. This practical tool may help clinicians conduct early prognostic assessments and develop treatment plans.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.